共 50 条
- [34] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients [J]. Medical Oncology, 2013, 30
- [37] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5559 - 5572